| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9030 | 
      | Human Intestinal Absorption | HIA+ | 0.9896 | 
      | Caco-2 Permeability | Caco2+ | 0.6297 | 
      | P-glycoprotein Substrate | Non-substrate | 0.5520 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.5442 | 
                                                     | Inhibitor | 0.5393 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8358 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.6440 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8247 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.9091 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.5773 | 
      | CYP450 1A2 Inhibitor | Inhibitor | 0.9237 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.7521 | 
        | CYP450 2D6 Inhibitor | Inhibitor | 0.9047 | 
      | CYP450 2C19 Inhibitor | Inhibitor | 0.9101 | 
      | CYP450 3A4 Inhibitor | Inhibitor | 0.7960 | 
      | CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.7534 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9676 | 
                                                                    | Non-inhibitor | 0.9569 | 
      | AMES Toxicity | AMES toxic | 0.7091 | 
      | Carcinogens | Non-carcinogens | 0.9472 | 
      | Fish Toxicity | High FHMT | 0.9360 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9782 | 
      | Honey Bee Toxicity | High HBT | 0.8451 | 
      | Biodegradation | Not ready biodegradable | 0.7842 | 
      | Acute Oral Toxicity | III | 0.5132 | 
      | Carcinogenicity (Three-class) | Warning | 0.4385 |